Respiratory monitoring devices market seen reaching $2.89 billion by 2030

The respiratory monitoring devices market is projected to grow from $1.81 billion in 2025 to $1.99 billion in 2026, with Asia-Pacific leading the category in 2025. The Business Research Company says demand is being driven by pneumonia cases, remote monitoring, home diagnostics and AI-based clinical tools.

Why it matters: - The respiratory monitoring devices market is expanding as hospitals, clinics and home-care settings rely more on continuous tracking of breathing and vital signs. - The market is projected to reach $2.89 billion by 2030, underscoring rising demand for tools that can detect respiratory problems earlier and support more personalized care. - Rising pneumonia burden and broader use of remote patient monitoring are strengthening the case for these devices across clinical and home settings.

What happened: - The Business Research Company said the respiratory monitoring devices market is expected to rise from $1.81 billion in 2025 to $1.99 billion in 2026. - The report projects a compound annual growth rate of 10.0% from 2025 to 2026 and 9.8% through 2030. - Asia-Pacific led the market by regional size in 2025. - North America ranked as the second-largest regional market in 2025. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

The details: - Respiratory monitoring devices evaluate a patient’s respiratory system and often use body-worn patches to measure respiration and heart rates. - The report links historical growth to higher diagnosis rates of chronic respiratory diseases, more sleep disorder testing, greater hospital monitoring needs, smaller device designs and preventive healthcare adoption. - Future growth is expected to come from remote patient monitoring, connected health platforms, home diagnostic options, AI-driven clinical decision support and personalized respiratory care. - Emerging trends include wearable respiratory monitors, continuous remote monitoring systems, AI-based data analytics, home-based respiratory monitoring and early detection technologies. - The report says pneumonia is a major growth driver because respiratory monitoring can help track rates and other vital signs in real time. - The National Center for Biotechnology Information reported in January 2023 that pneumonia affects about 120 million people globally each year and causes about 1.3 million deaths. - The same report said nearly 80% of pediatric pneumonia deaths occur in children under age 2 in developing countries. - The 2026 market report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and key technology and future trend analysis.

Between the lines: - The market outlook points to a shift from hospital-only monitoring toward more connected, continuous and at-home respiratory care. - AI and wearable technology are emerging as the main product and workflow advantages, especially for early detection and ongoing monitoring. - Asia-Pacific’s lead suggests the biggest near-term commercial opportunity may be in high-growth health systems with expanding access to respiratory diagnostics.

What's next: - The market is expected to keep growing as connected health platforms and home diagnostics become more common. - Continued adoption of AI-based decision support and remote monitoring systems could accelerate device demand through 2030. - The report’s regional and segment analysis suggests future competition will likely focus on product differentiation, data analytics and home-use monitoring capabilities.

The bottom line: - Respiratory monitoring devices are moving from a niche clinical tool to a broader platform for early detection, remote care and personalized respiratory management.